An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke


Phase N/A Results N/A

Summary of Purpose

Study to evaluate the safety and efficacy of intravenous recombinant tissue Plasminogen Activator, alteplase, Actilyse® (rt-PA) (0.9 mg/kg) within 3 hours of symptom onset in acute ischemic stroke

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 August 2014.

1 Jun 2006 28 Aug 2014 1 Mar 2009 Unavailable 1 Aug 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample


Not available